chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Possible seizure 18 days later about 40 minutes to 1 hour. Hives within 30 days of vaccination. She had numerous reactions to first shot
Child was sitting in chair waiting for the rest of her class to be vaccinated, and fainted and fell out of chair.  Nurse Practitioner instantly assessed child... respirations, heart rate, and blood pressure remained stable while child was monitored for 1 hour and when she continued to refuse to allow provider to touch arm, and continued to be flat affect and "glassy eyed," child was sent to ED where she was triaged and then sent home.
"Moderna COVID-19 Vaccine EUA"  On 04/24/2020 I woke up with the upper left side of my face, especially the eye area, swollen.
Left eyelid swelling, left facial and left upper extremity numbness (down sensitivity to light touch).
8/9/99 dizziness, intoxicated feeling, hot flash, tingling of arms & legs;8/23/99 unexplained h/a;
First dose, second dose due in 27 days  injection site: heat, hardness, swelling, red, pain - 2 hours after shot, 24 hours after it is still swollen, hot, and painful. ice did not bring it down at all  Other: fever 102.5 F even with tylenol, fatigue, back ache, headache, flushing of face, chills, body aches - occurred around 10 am the days after vaccination , currently 8:30 pm and still experiencing all listed effects
have brain ringing and it is debilitating; have brain ringing and it is debilitating; This is a spontaneous report from a contactable consumer. This consumer reported similar events for three patients. This is the third of three reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot Number: Not Provided) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient stated that she have brain ringing and it is debilitating. Outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : PFIZER INC-2021313764 Same reporter/drug/events. different patient; PFIZER INC-2021330802 Same reporter/drug/events. different patient
This spontaneous report has been received from a pharmacist via a company representative, referring to a 66 year old female patient. The patient had no medical history, concurrent conditions, drug and allergy history to be reported. On 09-OCT-2018, the patient was vaccinated with PNEUMOVAX 23, intramuscularly (strength, dose, frequency, lot # and expiration date were not provided) for vaccination. Concomitant therapies included FLUAD. The reporter stated that on 12-OCT-2018, the patient contacted pharmacy to explain that she had experienced fever and chills on 09-OCT-2018 (also reported as almost immediately after receiving PNEUMOVAX 23. Furthermore, it was reported that on an unspecified date after receiving PNEUMOVAX 23, the patient was examined by an unspecified physician, who explained that the patient had a virus. The patient had treated herself with TYLENOL and MOTRIN. The outcome of viral infection was reported as not recovered. At the time of the reporting time, the causality between the aforementioned event and PNEUMOVAX 23 was not reported.
DEATH; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin)total 1 dose, start therapy date were not reported for prophylactic vaccination. The Batch number was not reported. The Company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the patient experienced death. On an unspecified date, the patient died from unknown cause of death. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: 20210356723- Covid-19 vaccine ad26.cov2.s-Death. This event is considered unassessable. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Pt received 2nd vax felt itchy & broke out in hives (upper torso). Treated /w Atarax & Benadryl. Dx urticarial rash is resolving, hypersensitivity to vaccine
reports inj site painful shortly p/vax given;later noted itching, pain, redness & swelling, (diameter 4"-5" x 6" upper rt arm @ worst);gradually subsided contacted by phone 18OCT95 nearly all gone no tx
rapid test and it was COVID positive; basic flu symptoms; Soreness; Fever; Fatigue; second dose might be over 42 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (second dose might be over 42 days), COVID-19 (rapid test and it was COVID positive), INFLUENZA (basic flu symptoms), PAIN (Soreness) and PYREXIA (Fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Allergy (Allergy NOS). Concomitant products included FLUTICASONE for Allergy, METOPROLOL for Blood pressure, VITAMIN C [ASCORBIC ACID] for Vitamin C supplementation, VITAMIN D NOS for Vitamin D supplementation, ZINC for Zinc supplementation.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (second dose might be over 42 days), PAIN (Soreness), PYREXIA (Fever) and FATIGUE (Fatigue). On 23-Mar-2021, the patient experienced INFLUENZA (basic flu symptoms). On 24-Mar-2021, the patient experienced COVID-19 (rapid test and it was COVID positive). The patient was treated with IBUPROFEN for Fever and Headache, at a dose of 200 mg, 3 tablets; PREDNISONE at a dose of 10 mg and AMOXICILLIN, CLAVULANIC ACID (AUGMENTIN BAMBINI) at a dose of 875 mg. On 22-Mar-2021, PRODUCT DOSE OMISSION ISSUE (second dose might be over 42 days) had resolved. At the time of the report, COVID-19 (rapid test and it was COVID positive), INFLUENZA (basic flu symptoms), PAIN (Soreness), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Body temperature: 101f (High) 101F. On 24-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. On 10-May-2021, Body temperature: 100.7f (High) 100.7F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up information received on 10-May-2021,contains significant information, added new event. On 10-May-2021: Follow-up information received on 11-May-2021,contains significant information. Added Medical History, Lab data, Suspect drug details, Concomitant medications
Information has been received from a physician concerning a 16 year old male patient with no previous history of seizures who in March 2010, was vaccinated with the first dose of GARDASIL (route and lot# not reported). In June 2010, the patient experienced tonic-clonic seizure and was hospitalized. "Computerized Tomography and Magnetic Resonance Imaging were normal." On an unspecified date the patient fully recovered from tonic-clonic seizure. Additional information has been requested. The patient's sibling also experienced tonic-clonic seizure after receiving the first dose of GARDASIL. (WAES # 1010USA00612).
This six month old patient was given an HAV prior to start date 12, months. Six months old is an acceptable age to receive the vaccine if travel to an endemic region is planned, however no such travel planned in this case. No adverse event to vaccine.
One tonsil is enlarged with surrounding abscess or cyst; possibly tonsilitis; swollen throat; throat discomfort; problems swallowing; enlarged tonsils; Initial information received on 28-Feb-2020 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a adult male patient (unknown age) who experienced one tonsil is enlarged with surrounding abscess or cyst and possibly tonsilitis, while he received vaccine RABIES (HDC) VACCINE [IMOVAX RABIES].  Medical history included kitten bite [Animal bite].  Medical treatment, vaccination and family history were not provided.   In October 2019, the patient received a dose of suspect RABIES (HDC) VACCINE (lot number and expiry date not reported) via an unknown route at an unknown administration site for post exposure immunization.  On an unknown date, the patient developed non-serious one tonsil is enlarged with surrounding abscess or cyst (tonsillar cyst) and possibly tonsilitis (tonsillitis) with the symptoms of swollen throat (pharyngeal swelling), throat discomfort (oropharyngeal discomfort), problems swallowing (dysphagia) and enlarged tonsils (tonsillar hypertrophy) (unknown latency) following the administration of RABIES (HDC) VACCINE.  Relevant laboratory test results included: Computerised tomogram - On an unknown date: to rule out tonsil cysts vs. tonsillitis.  Final diagnosis was tonsilitis and tonsillar cyst.  The patient is being treated by ENT [Ear, Nose, Throat].  The outcome was unknown for all the events.  Information on batch number was requested.
Breakthrough case admission after 3 vaccines pfizer 3/4/21 Lot# EN6198;  Pfizer 3/25/21 Lot# En6208;  Pfizer 10/21/21 Lot# Ew0183
Right arm and injection site with hives and itching. Fluid in bilateral wrist and bilateral knees. Palms and forearms with hives and itching. Exactly 24 hours after injection.
On day of onset  (09/16/2021)felt tired, nauseous, lightheaded.  Unable to eat; slept most of day and night.  On 09/17/2021 arose at 5:00 AM, nauseous & lightheaded; between 5:15 AM and 5:30 AM fainted in bathroom, wrenched and bruised back, bruise on head.
Varicella given  3 weeks early from 12 months old,  vaccine that shall been given was Vaxelis dose number 2
Awakened the day after injection feeling achy all over, tired and had a fever. Felt like I had the flu.  Later that day I noticed red streak that wrapped around my arm near the injection site about 2 inches wide. I felt so weak at times during the day that I had to lay down and rest before I could finish my errands for the day. I took TYLENOL every 4 hours and took a dose of BENADRYL that night. Today I feel much better. The fever and aches are gone. The rash is still visible but improved.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 61 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing); "diabetic" (unspecified if ongoing); "obese" (unspecified if ongoing); "hypertensive" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. From 19Jun2022 to 23Jun2022, the patient received nirmatrelvir; ritonavir (PAXLOVID) for treatment of COVID-19. On 28Jun2022 (on Tuesday),  the patient experienced a return of covid symptoms that were worse than before nirmatrelvir; ritonavir. Coughing and breathing problems were still an issue as of 02Jul2022. No medical help available due to holiday weekend.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt on 4/26/2021 had episode of svt, resolved with adenosine at outside er.  recurrent episode today
This non-serious initial spontaneous case, was received on 29-Aug-2017 from a pharmacist, concerning a 26-year-old adult female patient. The patient's medical history and concomitant medications were not reported. On 28-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, batch number: 178601 (as reported), expiry date: Apr-2018, route of administration, anatomical location: not reported), explicitly coded as inappropriate age at vaccine administration. It was reported that, no adverse effects were noted. The outcome of the events was not reported. The reporter assessed the events as non-serious.
PATIENT REPORTED BACK THAT SHE HAD NOTED CHEST DISCOMFORT THAT COVERED THE LEFT SIDE OF HER CHEST AND THE WHOLE LEFT ARM AND SHOULDER. THIS WAS AN EXAMPLE OF POTENTIAL OUTCOME PRIOR TO BEING VACCINATED BY THOSE VACCINATING. THIS PAIN WAS NOTED WITHIN THE FIRST WEEK AFTER THE VACCINATION BUT WAS NOTE NOTED AFTER THIS TIME. SHE WAS SEEN BY A PHYSICIAN, ON THE 17 TH DAY AFTER THE VACCINATION FOR COMPLAINT OF JOINT PAIN BUT NOT FOR CHEST OR ARM PAIN.
blood in urine; blood on my ear; This is a spontaneous report from a contactable consumer or other non hcp (Patient).  A 72-years-old male patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EM9809), via an unspecified route of administration, administered in Arm Left on 28Feb2021 (Age at vaccination: 72-years-old) as single dose for covid-19 immunization. Medical history included atrial fibrillation and Blood pressure both from an unknown date and unknown if ongoing. Concomitant medication included bisoprolol (BISOPROLOL) taken for an unspecified indication start and stop date were not reported, rivaroxaban (XARELTO) taken for Heart murmur and atrial fibrillation start and stop date were not reported. It was reported that patient had the shot and he on blood thinner and four days after the shot he got little blood in his urine. So, he was wondering, was that any effect of the shot. Upon date 16Mar2021 it was reported that had a problem after had his second shot within 3 days he went to the bathroom and he had blood on his ear and for about 3 times he went to the bathroom. he want to know is that from the shot or should he go see a doctor. Upon date 16Mar2021 it was reported that. he was wondering, he had his shot, two shots, the second shot he got about three days ago and then after the shot, he had blood in my urine. Three days after his second shot, he had blood in my urine for about two to three times. Patient further stated, all he want to know is if other people has had that or is it common or should he go to another doctor or what is going on. Patient was not received any treatment for the events. The patient underwent lab tests and procedures which included blood urine: blood in urine. The outcome for the evens was reported as unknown at the time this report.   No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date, the patient was inadvertently vaccinated with a dose of M-M-R II intramuscularly, with lot # M045402 and expiration date of 14-NOV-2017 (strength and dose were unknown) for prophylaxis. No adverse effects were reported.
Large red induration, shot given 9/28, 3 x 4 cm on 9/29. Started on clindamycin on 9/30 induration now 6 x 7 cm. Area painful & sore.
Vesicles, papules and scabbed vesicles scattered <20, DX chicken pox post vaccination, TX Acyclovir. Vaccine given 4/18/2000, DX on 2/20/2006.
Low grade fever 98.8-99.1; Upset stomach; Muscle pain in Right arm; heavyness in moving; Right arm Tiredness; This is a spontaneous report from a contactable consumer (patient). This 59-years-old non-pregnant female consumer reported for herself that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6206, Expiry Date: not reported), via an unspecified route of administration, administered in right arm on 09Mar2021 (at the age of 59 years) as dose 2, single for covid-19 immunisation. Medical history included osteoarthritis, axinal peripheral Neuropathy "cryptogenic". Known allergies: Sulfur, 600mg or more of aspirin. Concomitant medications in two weeks: ubidecarenone (COQ10 [UBIDECARENONE]), vaccinium myrtillus (MAXVISION), loratadine (ALLERCLEAR) and Clonazepam. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267, Expiry Date: not reported), via an unspecified route of administration, administered in right arm on 19Feb2021 at 14:15 (at the age of 59 years) as dose 1, single for covid-19 immunisation. On 10Mar2021 at 05:00, the patient experienced low grade fever 98.8-99.1, upset stomach, muscle pain in right arm/heaviness in moving, right arm tiredness. The patient underwent lab tests and procedures which included body temperature: 98.8-99.1 on 10Mar2021 (Low grade fever). It was unknown if treatment for AE was received or not. The outcome of events was recovered with lasting effects in 2021.  No follow-up attempts are possible. No further information is expected
Dose 2 first day: Metal taste in mouth, headache, tired Day 2: Widespread Moderate/Severe joint pain, mild headache, fatigue Day 3: Moderate joint pain, intermittent vertigo, stiff joints especially hands/wrist with numb pinching feel, fatigue Day 4: Mild achy joints, prickles in hands and feet.  Stiff joints especially hands, painful to grasp objects, numb feeling is wrists popping joints, fatigue Day 5 : aches are better, mostly knees, elbows, shoulders, hands and wrists. Wrists are still pinching, gnawing ache, fatigue Day 6-12 : Mild Burning, throbbing, gnawing, aching  joint pain, Muscle tightness, fatigue
Pt recvd 3 doses of Hep B vax 20MAR89, 20APR89, & 19SEP89 & 27DEC89 it was determined that the titer was neg; booster dose given 4JAN90 & 6MAR90 titer was neg; 2nd booster dose given 7APR90 & 25NOV90 titer was neg;
8 1/2 hrs. after receiving 2nd dose, right arm became very painful, right axillary lymph nodes enlarged, and right breast pain and swelling started.  Symptoms impeded function of arm.  Seen by a provider on 1/19/2021
accidentally injected 1600 patients with expired Moderna COVID 19 vaccine/Patient may have received vaccine after 30 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (accidentally injected 1600 patients with expired Moderna COVID 19 vaccine/Patient may have received vaccine after 30 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (accidentally injected 1600 patients with expired Moderna COVID 19 vaccine/Patient may have received vaccine after 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (accidentally injected 1600 patients with expired Moderna COVID 19 vaccine/Patient may have received vaccine after 30 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitants and treatments medications was reported.  The report provided is from a Nurse practitioner, reporting and enquiring regarding the expired vaccine vials. Details regarding dates administered and lot numbers (multiple) are mentioned in the report.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up information received on 20 Jul 2021 contains no significant information.
Pfizer Comirnaty vial was opened on Thursday 7/7/22 at 11:48 am. Vaccine was administered on Friday 7/8/22 at approx 3:15 pm.
uncontrollable crying starting at 5:00 pm 9/13/06 continued until 9/14/2006.  TYLENOL/MOTRIN for pain
The evening of the date the vaccine was administered, I slight soreness and swelling. This became more pronounced the following day (11/12) with the addition of inflammation. On 11/13 the arm was even more swollen, sore and inflamed. I went to an urgent care site and was told to go immediately to an Emergency Department. I did as instructed and was diagnosed with cellulitis. I was given an oral antibiotic and discharged withe caveat that if it became worse to return to the ED.  The swelling and inflammation continued to spread and I returned to the ED where I was given 4 doses of different antibiotics over the course of 19 hours.
JAW PAIN; This spontaneous report received from concerned a 56 year old male. The patient's concurrent conditions included alcohol user, and smoker, and other pre-existing medical conditions included the patient did not have any history of drug abuse or illicit drug use. the patient had no known allergies. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced jaw pain. The action taken with covid-19 vaccine was not applicable. The patient recovered from jaw pain. This report was non-serious. This case, from the same reporter is linked to 20210627868.
pt recvd vax; 5MAR95 total body rash & white coated tongue; to Md; blood work drawn;
Patient received 2nd HPV vaccine 2-27-08, and woke with hives on her neck and face 2-28-08. Slight itching.
7/7 patient received prevnar 20 and boostrix. 7/8 he started experiencing severe arm pain, faintness, lack of energy, and face/lip swelling  on 5/3 he got boostrix and pneumovax 23  so neither imz given on 7/7 were indicated and given unnecessarily. this along with his severe reaction which he went to the ER for is why I'm reporting . I also reported to corporate as an error
Rapid onset of severe back pain. Limited mobility. Treatment of chiropractic adjustments and deep tissue massages.
Headache - Triggered 1st migraine - 5 days of nausea, headache and dizziness. Missed 5 days of school, 2 office visits for evaluation and 1 emergency room visit for migraine abortant therapy. Continues Gastritis.
When coming for his 2nd dose, patient reported suffering short term memory loss around the time of receiving his 1st dose. When asked specifically when his memory loss started; he could not identify. He stated it may have started 5 weeks ago, or 4 weeks ago but could not say for certain that his memory loss manifested before or after his 1st Moderna dose. He reported his memory loss to his PCP, who still recommended he come for his 2nd dose.
No adverse event occurred, however patient was given the 5-11  year formulation (0.2 mL administered).  Submitting this to VAERS given requirement to report any COVID vaccine administration errors, even those that do not result in harm.  No adverse events reported, patient likely to repeat series at next appropriate date.